| 2022 | 2021 | 2020 | 2019 | 2018 | 2016 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 23,3 M € | +48.5% | 15,7 M € | -6.0% | 16,7 M € | +30.0% | 12,8 M € | -74.2% | 49,8 M € | +135.7% | 21,1 M € | +18.7% | 17,8 M € | -1.5% | 18,1 M € | +9.1% | 16,6 M € | -1.7% | 16,8 M € | +21.7% | 13,8 M € | +65.0% | 8,4 M € | -12.7% | 9,6 M € | +20.1% | 8,0 M € | +10.4% | 7,3 M € | |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1,6 M € | |||||||||||||||
| EBITDA | 94,0 k € | -96.1% | 2,4 M € | +77.9% | 1,4 M € | +102.5% | 668,8 k € | +106.0% | -11,1 M € | +12.6% | -12,7 M € | -1571.7% | 863,3 k € | -76.2% | 3,6 M € | +21.2% | 3,0 M € | -25.8% | 4,0 M € | +56.1% | 2,6 M € | +343.6% | -1,1 M € | -201.8% | 1,0 M € | +38.0% | 754,4 k € | +14.0% | 661,5 k € | |
| Operating profit | -438,9 k € | -124.3% | 1,8 M € | +71.2% | 1,1 M € | +134.8% | 449,9 k € | +103.0% | -15,0 M € | -7.3% | -14,0 M € | -6587.5% | 215,7 k € | -87.2% | 1,7 M € | +49.3% | 1,1 M € | -56.2% | 2,6 M € | +19.1% | 2,2 M € | +252.1% | -1,4 M € | -310.1% | 678,5 k € | +64.3% | 413,1 k € | +64.4% | 251,2 k € | |
| Profit/loss | -42,5 M € | -4713.3% | -883,8 k € | +95.9% | -21,3 M € | +38.7% | -34,7 M € | -141.4% | -14,4 M € | +0.8% | -14,5 M € | -145258.1% | 10,0 k € | -99.0% | 976,3 k € | +66.4% | 586,7 k € | -68.7% | 1,9 M € | -62.6% | 5,0 M € | +418.3% | -1,6 M € | -372.1% | 578,6 k € | +48.0% | 391,0 k € | +25.5% | 311,7 k € | |
| Equity | 290,2 M € | +16.1% | 249,9 M € | +3.5% | 241,5 M € | +24.0% | 194,7 M € | +2.3% | 190,4 M € | +64.1% | 116,0 M € | +723.9% | 14,1 M € | +408.0% | 2,8 M € | -30.7% | 4,0 M € | +0.9% | 4,0 M € | +10.4% | 3,6 M € | +232.0% | 1,1 M € | -57.7% | 2,6 M € | +29.3% | 2,0 M € | +24.5% | 1,6 M € | |
| Total assets | 513,6 M € | +11.6% | 460,1 M € | +3.1% | 446,1 M € | +76.5% | 252,7 M € | -2.8% | 260,0 M € | +77.6% | 146,5 M € | +532.2% | 23,2 M € | +74.4% | 13,3 M € | +8.9% | 12,2 M € | -10.0% | 13,5 M € | -3.2% | 14,0 M € | +92.9% | 7,2 M € | -2.7% | 7,5 M € | +28.2% | 5,8 M € | +58.2% | 3,7 M € | |
| Cash | 27,6 M € | +61.9% | 17,0 M € | -86.2% | 123,1 M € | +198.5% | 41,2 M € | -64.8% | 117,2 M € | +8572.5% | 1,4 M € | +31.7% | 1,0 M € | +21.3% | 846,0 k € | +26.0% | 671,6 k € | +323.9% | 158,4 k € | -65.6% | 460,5 k € | -54.6% | 1,0 M € | +59.3% | 636,0 k € | +69.6% | 375,0 k € | +37.1% | 273,5 k € | |
| Debts | 221,0 M € | +5.4% | 209,7 M € | +2.8% | 203,9 M € | +253.8% | 57,6 M € | -16.9% | 69,3 M € | +170.6% | 25,6 M € | +183.5% | 9,0 M € | -13.3% | 10,4 M € | +30.6% | 8,0 M € | -16.3% | 9,5 M € | -8.0% | 10,4 M € | +74.1% | 6,0 M € | +23.1% | 4,8 M € | +26.1% | 3,8 M € | +83.8% | 2,1 M € | |
| Staff | 40 | 41 | 41 | 50 | 55 | 55 | 29,4 | 26,1 | 29,6 | 30,4 | 23 | 24 | 21,1 | 18,6 | 16,8 | |||||||||||||||
Public limited company · Liège · incorporated on 13/07/1999 · 40,0 ETP
Company — Opening of bankruptcy.
Public limited company loss-making in the latest fiscal year. Cash position rising (+61.9%).
Solid counterparty for a standard engagement.
Mithra Pharmaceuticals is a Public limited company incorporated in 1999. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Liège. It employs on average 40,0 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette